Milk of Magnesia
*Company:
Chefaro Ireland DACStatus:
No Recent UpdateLegal Category:
Supply through general saleActive Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 24 January 2023
File name
ie-spc-clean.pdf
Reasons for updating
- Document format updated
Legal category:Supply through general sale
Updated on 10 June 2020
File name
ie-spc-clean- consolidated-Nov2019.pdf
Reasons for updating
- Improved presentation of SPC
Legal category:Supply through general sale
Updated on 10 June 2020
File name
1.3.2-ie-mockup-leaflet-07-04-2020 2.pdf
Reasons for updating
- Improved presentation of PIL
Updated on 21 April 2020
File name
131-uk-spc-rfi3-clean-17-03-2020.pdf
Reasons for updating
- Improved presentation of SPC
Legal category:Supply through general sale
Updated on 21 April 2020
File name
131-uk-label-pil-rfi3-clean-17-03-2020.pdf
Reasons for updating
- Change to other sources of information section
Updated on 16 April 2020
File name
1.3.1-ie-label-leaflet-clean_07-04-2020.pdf
Reasons for updating
- Addition of manufacturer
- Change to date of revision
Updated on 27 January 2020
File name
ie-pl-clean-consolidated-Nov2019.pdf
Reasons for updating
- Change to other sources of information section
Updated on 21 January 2020
File name
ie-pl-clean-consolidated-Nov2019.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
Free text change information supplied by the pharmaceutical company
Poduct information updated in line with the CCDS, with additional updates in line with the QRD template.
Updated on 21 January 2020
File name
ie-spc-clean- consolidated-Nov2019.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
- Change to MA holder contact details
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
|
Poduct information updated in line with the CCDS, with additional updates in line with the QRD template. |
Updated on 21 January 2020
File name
uk-pl-clean-0000.pdf
Reasons for updating
- Change to Section 1 - what the product is
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 3 - overdose, missed or forgotten doses
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
- Change to section 6 - what the product contains
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
The SmPC and PIL were updated in line with the newly created CCDS, in line with CMDh and MHRA guidance, all changes have been included in the CCDS due to their medical relevance, and rely on the same supporting data package.
Updated on 26 July 2019
File name
ie-mockup-label.pdf
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - manufacturer
Updated on 07 June 2019
File name
ie-label-leaflet-approved 19-11-2018.pdf
Reasons for updating
- Change to MA holder contact details
Updated on 07 June 2019
File name
ie-spc-clean app 31-05-2019.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
Legal category:Supply through general sale
Updated on 23 November 2018
File name
ie-spc-approved-19-11-2018.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Updated on 21 November 2018
File name
ie-label-leaflet-approved 19-11-2018.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 4 - how to report a side effect
Updated on 20 November 2017
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale
Updated on 20 November 2017
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 17 November 2017
File name
PIL_16384_809.pdf
Reasons for updating
- New PIL for new product
Updated on 17 November 2017
Reasons for updating
- Change to MA holder contact details
Updated on 26 June 2015
Reasons for updating
- New PIL for new product
Updated on 15 September 2014
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 14 February 2014
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Supply through general sale
Free text change information supplied by the pharmaceutical company
Updated on 23 August 2013
Reasons for updating
- New SPC for new product
Legal category:Supply through general sale